NKMAX Co., Ltd.
Develops NK cell-based therapies, diagnostics, and biological products.
182400 | KO
Overview
Corporate Details
- ISIN(s):
- KR7182400002
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 돌마로 172 정자동, 헬스케어혁신파크 1층및6층, 성남시
- Website:
- https://nkmax.com/
- Sector:
- Manufacturing
Description
NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-17 00:00 |
불성실공시법인지정예고 (공시번복)
|
Korean | 5.2 KB | ||
| 2024-05-16 00:00 |
분기보고서 (2024.03)
|
Korean | 1.2 MB | ||
| 2024-05-14 00:00 |
소송등의제기ㆍ신청(경영권분쟁소송) (직무집행정지가처분신청)
|
Korean | 6.0 KB | ||
| 2024-05-14 00:00 |
[기재정정]소송등의제기ㆍ신청(경영권분쟁소송) (직무집행정지가처분신청)
|
Korean | 10.8 KB | ||
| 2024-05-08 00:00 |
기타시장안내 (공시위반제재금 미납에 따른 가중벌점 부과 )
|
Korean | 3.4 KB | ||
| 2024-04-26 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 937.2 KB | ||
| 2024-04-26 00:00 |
투자판단관련주요경영사항 (이사회결의무효확인 소송의 제기)
|
Korean | 6.1 KB | ||
| 2024-04-26 00:00 |
투자판단관련주요경영사항 (이사회결의효력정지가처분 신청)
|
Korean | 6.2 KB | ||
| 2024-04-19 00:00 |
기타시장안내 (상장폐지 관련 이의신청서 접수 및 개선기간 부여)
|
Korean | 3.9 KB | ||
| 2024-04-19 00:00 |
주권매매거래정지기간변경 (개선기간 부여)
|
Korean | 5.5 KB | ||
| 2024-04-18 00:00 |
주요사항보고서(회생절차개시신청)
|
Korean | 4.6 KB | ||
| 2024-04-18 00:00 |
주권매매거래정지기간변경 (회생절차 개시신청)
|
Korean | 5.3 KB | ||
| 2024-04-17 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 21.9 KB | ||
| 2024-04-17 00:00 |
기타주요경영사항 (제3자배정 유상증자결정 철회)
|
Korean | 4.8 KB | ||
| 2024-04-17 00:00 |
풍문또는보도에대한해명 (최종답변)
|
Korean | 8.3 KB |
Automate Your Workflow. Get a real-time feed of all NKMAX Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NKMAX Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NKMAX Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
